Literature DB >> 21500000

Electrocardiography teaching in Canadian family medicine residency programs: a national survey.

Baldeep Paul1, Adrian Baranchuk.   

Abstract

OBJECTIVE: Electrocardiography (ECG) interpretation is an essential skill for a family physician. Teaching and learning electrocardiography is a difficult task, in part due to the erosion of knowledge when interpretation is not part of a daily activity. The objective of this study was to assess the current status of electrocardiography teaching in Canadian family medicine residency programs.
METHODS: A national survey was designed to specifically address the status of the ECG teaching curricula. This national survey was electronically sent to the family medicine program directors of all 17 Canadian accredited medical schools.
RESULTS: Approximately 75% of the schools responded to the survey. There was a great variance among Canadian family medicine residency programs with respect to the time allotment, ECG training location, training faculty, and teaching methods utilized. The goals of each respective program are also quite wide-ranging.
CONCLUSIONS: Family medicine residency programs across Canada are quite diverse regarding ECG training curricula and its goals. The need for a homogeneous way of teaching and evaluating has been identified.

Mesh:

Year:  2011        PMID: 21500000

Source DB:  PubMed          Journal:  Fam Med        ISSN: 0742-3225            Impact factor:   1.756


  2 in total

1.  Improving ECG Competence in Medical Trainees in a UK District General Hospital.

Authors:  Christopher McAloon; Helen Leach; Simrat Gill; Arun Aluwalia; Jasper Trevelyan
Journal:  Cardiol Res       Date:  2014-05-15

2.  Is computer-assisted instruction more effective than other educational methods in achieving ECG competence among medical students and residents? Protocol for a systematic review and meta-analysis.

Authors:  Charle André Viljoen; Rob Scott Millar; Mark E Engel; Mary Shelton; Vanessa Burch
Journal:  BMJ Open       Date:  2017-12-26       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.